Literature DB >> 25674388

Heterozygous mutation of c.3521C>T in COL1A1 may cause mild osteogenesis imperfecta/Ehlers-Danlos syndrome in a Chinese family.

Xianlong Shi1, Yanqin Lu1, Yanzhou Wang2, Yu-Ang Zhang1, Yuanwei Teng1, Wanshui Han3, Zhenzhong Han1, Tianyou Li2, Mei Chen3, Junlong Liu3, Fengling Fang3, Conghui Dou3, Xiuzhi Ren3, Jinxiang Han1.   

Abstract

Osteogenesis imperfecta (OI) is an inheritable connective tissue disorder with a broad clinical heterozygosis, which can be complicated by other connective tissue disorders like Ehlers-Danlos syndrome (EDS). OI/EDS are rarely documented. Most OI/EDS mutations are located in the N-anchor region of type I procollagen and predominated by glycine substitution. We identified a c.3521C>T (p.A1174V) heterozygous mutation in COL1A1 gene in a four-generation pedigree with proposed mild OI/EDS phenotype. The affected individuals had blue sclera and dentinogenesis imperfecta (DI) was uniformly absent. The OI phenotype varied from mild to moderate, with the absence of scoliosis and increased skin extensibility. Easy bruising, joint dislocations and high Beighton score were present in some affected individuals. EDS phenotype is either mild or unremarkable in some individuals. The mutation is poorly conserved and in silico prediction support the relatively mild phenotype. The molecular mechanisms of the mutation that leads to the possible OI/EDS phenotype should be further identified by biochemical analysis of N-propeptide processing and steady state collagen analysis.

Entities:  

Keywords:  Ehlers-Danlos syndrome; Osteogenesis imperfecta; in silico prediction; mutations; type I collagen

Year:  2015        PMID: 25674388      PMCID: PMC4322595          DOI: 10.5582/irdr.2014.01039

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  23 in total

1.  The Human Collagen Mutation Database 1998.

Authors:  R Dalgleish
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

2.  The human type I collagen mutation database.

Authors:  R Dalgleish
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

3.  Solving the mystery of procollagen chain selectivity.

Authors:  Neil J Bulleid
Journal:  Nat Struct Mol Biol       Date:  2012-10       Impact factor: 15.369

4.  Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing.

Authors:  Wayne A Cabral; Elena Makareeva; Alain Colige; Anne D Letocha; Jennifer M Ty; Heather N Yeowell; Gerard Pals; Sergey Leikin; Joan C Marini
Journal:  J Biol Chem       Date:  2005-02-22       Impact factor: 5.157

5.  Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral.

Authors:  S V Tavtigian; A M Deffenbaugh; L Yin; T Judkins; T Scholl; P B Samollow; D de Silva; A Zharkikh; A Thomas
Journal:  J Med Genet       Date:  2005-07-13       Impact factor: 6.318

6.  Ehlers-Danlos syndrome type VII: a single base change that causes exon skipping in the type I collagen alpha 2(I) chain.

Authors:  A C Nicholls; J Oliver; D V Renouf; J McPheat; A Palan; F M Pope
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

7.  Identification of a new heterozygous point mutation in the COL1A2 gene leading to skipping of exon 9 in a patient with joint laxity, hyperextensibility of skin and blue sclerae. Mutations in brief no. 166. Online.

Authors:  S Feshchenko; J Brinckmann; H W Lehmann; H G Koch; P K Müller; S Kügler
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

8.  Single molecule effects of osteogenesis imperfecta mutations in tropocollagen protein domains.

Authors:  Alfonso Gautieri; Simone Vesentini; Alberto Redaelli; Markus J Buehler
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

9.  Molecular and mesoscale mechanisms of osteogenesis imperfecta disease in collagen fibrils.

Authors:  Alfonso Gautieri; Sebastien Uzel; Simone Vesentini; Alberto Redaelli; Markus J Buehler
Journal:  Biophys J       Date:  2009-08-05       Impact factor: 4.033

10.  Characterization of a COL1A1 splicing defect in a case of Ehlers-Danlos syndrome type VII: further evidence of molecular homogeneity.

Authors:  M D'Alessio; F Ramirez; B D Blumberg; M K Wirtz; V H Rao; M D Godfrey; D W Hollister
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

View more
  4 in total

1.  Osteogenesis imperfecta type III/Ehlers-Danlos overlap syndrome in a Chinese man.

Authors:  Yanqin Lu; Yanzhou Wang; Frank Rauch; Hu Li; Yao Zhang; Naixiang Zhai; Jian Zhang; Xiuzhi Ren; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2018-02

2.  Dental Manifestations of Ehlers-Danlos Syndromes: A Systematic Review.

Authors:  Ines Kapferer-Seebacher; Dagmar Schnabl; Johannes Zschocke; F Michael Pope
Journal:  Acta Derm Venereol       Date:  2020-03-25       Impact factor: 3.875

Review 3.  Oral manifestations of Ehlers-Danlos syndromes.

Authors:  Ulrike Lepperdinger; Johannes Zschocke; Ines Kapferer-Seebacher
Journal:  Am J Med Genet C Semin Med Genet       Date:  2021-11-06       Impact factor: 3.359

4.  Whole exome sequencing links dental tumor to an autosomal-dominant mutation in ANO5 gene associated with gnathodiaphyseal dysplasia and muscle dystrophies.

Authors:  T V Andreeva; T V Tyazhelova; V N Rykalina; F E Gusev; A Yu Goltsov; O I Zolotareva; M P Aliseichik; T A Borodina; A P Grigorenko; D A Reshetov; E K Ginter; S S Amelina; R A Zinchenko; E I Rogaev
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.